BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Hassan AE. An observational cohort study to assess N-acetylglucosamine for COVID-19 treatment in the inpatient setting. Ann Med Surg (Lond) 2021;68:102574. [PMID: 34306677 DOI: 10.1016/j.amsu.2021.102574] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
Number Citing Articles
1 Sharma P, Joshi T, Joshi T, Mathpal S, Maiti P, Nand M, Chandra S, Tamta S. In silico screening of natural compounds to inhibit interaction of human ACE2 receptor and spike protein of SARS-CoV-2 for the prevention of COVID-19. J Biomol Struct Dyn 2023;41:646-58. [PMID: 34854365 DOI: 10.1080/07391102.2021.2010599] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
2 Wu Y, Liu J, Han X, Meng X, Li M, Wang J, Xue H, Yang Y, Xu P, Tao F. Eliminating host-guest incompatibility via enzyme mining enables the high-temperature production of N-acetylglucosamine. iScience 2023;26:105774. [PMID: 36636338 DOI: 10.1016/j.isci.2022.105774] [Reference Citation Analysis]